Leidos (NYSE:LDOS) Raised to Strong-Buy at Cantor Fitzgerald

Leidos (NYSE:LDOS) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a research note issued to investors on Thursday,Zacks.com reports.

Other equities research analysts have also issued research reports about the company. Barclays boosted their price target on Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. TD Cowen lowered Leidos from a “buy” rating to a “hold” rating and reduced their price objective for the company from $200.00 to $165.00 in a research note on Wednesday, January 8th. Truist Financial decreased their target price on shares of Leidos from $205.00 to $185.00 and set a “buy” rating for the company in a research note on Friday, November 22nd. Citigroup raised their price objective on Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Finally, The Goldman Sachs Group cut shares of Leidos from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $228.00 to $153.00 in a research report on Thursday, December 12th. Five analysts have rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $179.47.

Leidos Trading Up 1.1 %

NYSE:LDOS opened at $142.34 on Thursday. The firm has a 50 day moving average of $150.20 and a 200 day moving average of $157.78. The company has a quick ratio of 1.15, a current ratio of 1.23 and a debt-to-equity ratio of 0.87. Leidos has a 52 week low of $112.53 and a 52 week high of $202.90. The stock has a market capitalization of $18.99 billion, a price-to-earnings ratio of 16.21, a PEG ratio of 0.92 and a beta of 0.66.

Insider Buying and Selling at Leidos

In other Leidos news, Director Noel B. Geer bought 2,000 shares of Leidos stock in a transaction on Wednesday, November 20th. The shares were bought at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the transaction, the director now directly owns 2,000 shares of the company’s stock, valued at $322,260. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.96% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. FMR LLC lifted its holdings in shares of Leidos by 27.8% in the 3rd quarter. FMR LLC now owns 2,405,726 shares of the aerospace company’s stock worth $392,133,000 after acquiring an additional 522,764 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Leidos by 13.1% during the third quarter. JPMorgan Chase & Co. now owns 3,504,392 shares of the aerospace company’s stock worth $571,216,000 after purchasing an additional 405,256 shares in the last quarter. International Assets Investment Management LLC boosted its position in shares of Leidos by 24,194.3% during the third quarter. International Assets Investment Management LLC now owns 377,047 shares of the aerospace company’s stock worth $61,459,000 after buying an additional 375,495 shares during the period. Allspring Global Investments Holdings LLC grew its stake in shares of Leidos by 51.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock valued at $136,491,000 after buying an additional 283,558 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of Leidos in the 4th quarter valued at $40,402,000. Institutional investors and hedge funds own 76.12% of the company’s stock.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.